Clostridium difficile colitis and peritoneal dialysis associated peritonitis: 'Difficile' treatment considerations

被引:0
|
作者
Giuliani, Anna [1 ,2 ,7 ]
Lerco, Silvia [2 ,3 ]
Manani, Sabrina Milan [1 ,2 ]
Marcello, Matteo [2 ,4 ]
Tantillo, Ilaria [1 ,2 ]
Nicolin, Roberto [5 ]
Ronco, Claudio [2 ,6 ]
Zanella, Monica [1 ,2 ]
机构
[1] San Bortolo Hosp, Dept Nephrol Dialysis & Transplantat, Vicenza, Italy
[2] Int Renal Res Inst Vicenza IRRIV, Milan, Italy
[3] Univ Padua, Dept Med Nephrol, Dialysis & Transplantat Unit, Padua, Italy
[4] Libera Univ V e Salute San Raffaele, Milan, Italy
[5] St Bortolo Hosp, Dept Infect Dis, Vicenza, Italy
[6] Univ Padua, Dept Med DIMED, Padua, Italy
[7] San Bortolo Hosp, Dept Nephrol Dialysis & Transplantat, Viale Rodolfi,37, I-36100 Vicenza, Italy
来源
PERITONEAL DIALYSIS INTERNATIONAL | 2023年 / 43卷 / 02期
关键词
Clostridium difficile; diarrhoea; peritoneal dialysis; peritonitis; CHRONIC KIDNEY-DISEASE;
D O I
10.1177/08968608221132431
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Peritoneal dialysis (PD) associated peritonitis is the leading cause of PD discontinuation and haemodialysis transfer. Current guidelines strongly recommend prompt initiation of empiric broad-spectrum intraperitoneal antibiotics, with suspected peritonitis. Clostridium difficile colitis is one of the most common healthcare-associated infections, with increased morbidity and mortality among end-stage kidney disease patients. Clinical presentation is mainly characterised by diarrhoea of varying severity, which may eventually evolve into toxic megacolon and paralytic ileus. However, PD patients with Clostridium difficile infection (CDI) may also have colitis-triggered peritonitis, presenting challenging scenario for antibiotic treatment strategy, since broad-spectrum antibiotics against peritonitis may worsen CDI-related colitis, while inappropriate or discontinuation of antibiotic therapy may worsen peritonitis. Currently, guidelines on peritonitis management do not include such challenging clinical situations, although increasingly common. We herein describe a case of a patient, with culture-negative PD associated peritonitis and CDI, presenting with diarrhoea, abdominal pain and cloudy effluent.
引用
收藏
页码:182 / 185
页数:4
相关论文
共 50 条
  • [41] CLOSTRIDIUM-DIFFICILE-ASSOCIATED DIARRHEA AND COLITIS
    GERDING, DN
    JOHNSON, S
    PETERSON, LR
    MULLIGAN, ME
    SILVA, J
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1995, 16 (08): : 459 - 477
  • [42] CLOSTRIDIUM-DIFFICILE COLITIS NOT ASSOCIATED WITH ANTIBIOTHERAPY
    VANGOSSUM, A
    ADLER, M
    SERRUYS, E
    VANGOSSUM, M
    DELTENRE, M
    ACTA GASTRO-ENTEROLOGICA BELGICA, 1984, 47 (01): : 55 - 57
  • [43] Fulminant colitis associated to Clostridium difficile infection
    Bannura C, Guillermo
    Ross R, Gonzalo
    Gabler N, Fernando
    Esperguel G, Carlos
    REVISTA CHILENA DE CIRUGIA, 2012, 64 (04): : 383 - 386
  • [44] Exploring the Pathogenesis of Clostridium Difficile Associated Colitis
    Beck, Paul L.
    DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (09) : 2558 - 2558
  • [45] THE EPIDEMIOLOGY OF CLOSTRIDIUM-DIFFICILE ASSOCIATED COLITIS
    LARSON, HE
    JOURNAL OF MEDICAL MICROBIOLOGY, 1983, 16 (02) : R9 - R9
  • [46] Clostridium difficile associated infection, diarrhea and colitis
    Hookman, Perry
    Barkin, Jamie S.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (13) : 1554 - 1580
  • [47] Intravenous metronidazole for the treatment of Clostridium difficile colitis
    Friedenberg, F
    Fernandez, A
    Kaul, V
    Niami, P
    Levine, GM
    DISEASES OF THE COLON & RECTUM, 2001, 44 (08) : 1176 - 1180
  • [48] CLOSTRIDIUM DIFFICILE IN PERITONEAL-DIALYSIS (PD) PATIENTS (PATIENTS)
    MISKELL, CA
    ZIMMERMAN, SW
    PERITONEAL DIALYSIS INTERNATIONAL, 1988, 8 (01): : 90 - 90
  • [49] DIAGNOSIS AND TREATMENT OF CLOSTRIDIUM-DIFFICILE COLITIS
    FEKETY, R
    SHAH, AB
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (01): : 71 - 75
  • [50] Peritonitis by Clostridium innocuum associated to peritoneal dialysis
    Aroca-Ferri, Maria
    Suarez-Hormiga, Laura
    Bosch-Benitez-Parodi, Elvira
    Bolanos-Rivero, Margarita
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2019, 32 (02) : 192 - 193